Related Experiment Video
Updated: May 19, 2026
09:19
Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
Published on: February 6, 2015
Effectiveness of oxaliplatin desensitization protocols
Susana Cortijo-Cascajares1, Inmaculada Nacle-López, Ignacio García-Escobar
1Department of Pharmacy, Hospital Universitario 12 de Octubre, Avda Cordoba s/n, 28041, Madrid, Spain. susana.cortijo@salud.madrid.org
Summary
Oxaliplatin desensitization protocols safely enable patients to continue chemotherapy after hypersensitivity reactions. These protocols are effective, with most patients experiencing no or only mild reactions, allowing treatment completion.
Area of Science:
- Oncology
- Clinical Pharmacology
- Immunology
Background:
- Hypersensitivity reactions (HSRs) to antineoplastic drugs necessitate treatment cessation.
- Alternative treatments may be less effective, tolerated, or more costly.
- Drug desensitization protocols offer a viable option to induce temporary tolerance.
Purpose of the Study:
- To evaluate the effectiveness and safety of oxaliplatin desensitization protocols.
- To determine if patients can continue oxaliplatin chemotherapy after experiencing HSRs.
Main Methods:
- Retrospective observational study (January 2006 - May 2011).
- Included patients with oxaliplatin-induced HSRs candidates for desensitization.
- Analyzed patient records for treatment, HSR, and desensitization protocol data.
Main Results:
- 53 desensitization protocols administered to 21 patients.
- 89% of protocols resulted in no new reactions.
- 11% of protocols had mild reactions, none severe enough to halt treatment.
- All patients successfully completed their desensitization protocols.
Conclusions:
- Oxaliplatin desensitization protocols are safe and effective.
- These protocols enable patients to continue essential oxaliplatin treatment despite prior HSRs.
